UBS O'Connor’s CME Group CME Stock Holding History

UBS O'Connor’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,900	Closed	-$6K	–	544
2015 Q2	$6K	Buy	+10,900	New	+$1.02M	﹤0.01%	732

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

UBS O'Connor's CME Position: Q4 2022 in Review

UBS O'Connor sold out of CME Group (CME) in Q4 2022, closing a stake of 16,000 shares — an estimated $2.83M sold.

UBS O'Connor first reported a position in CME in Q2 2015 and held it in 7 quarters. The position peaked at $4.57M in Q3 2017. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

UBS O'Connor reported no remaining CME Group position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 16,000 CME Group shares in Q4 2022, an estimated $2.83M.
UBS O'Connor first reported a position in CME Group in Q2 2015 and held it in 7 quarters.
UBS O'Connor's CME Group position peaked at $4.57M in Q3 2017.
1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.